scholarly journals Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

2018 ◽  
Vol 20 (7) ◽  
pp. 1602-1614 ◽  
Author(s):  
Cristian Guja ◽  
Juan P. Frías ◽  
Aniko Somogyi ◽  
Serge Jabbour ◽  
Hui Wang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Randomized Study ◽  
Exenatide Qw

scholarly journals ESTIMATING THE COST TO SOCIETY FOR EXENATIDE QW AND INSULIN GLARGINE IN THE UNITED STATES FOR THE TREATMENT OF TYPE 2 DIABETES

2016 ◽  
Vol 19 (3) ◽  
pp. A201
Author(s):  
B.C. Wang ◽  
H. Nguyen ◽  
W. Furnback ◽  
G.F. Guzauskas ◽  
J. Hurd ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
The United States ◽  
Exenatide Qw ◽  
The Cost

Switching to Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control and Reduces Nocturnal Hypoglycemia in Patients (Pts) with Type 2 Diabetes (T2DM) on Basal Insulin Supported Oral Therapy (BOT)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1020-P ◽  
Author(s):  
JOCHEN SEUFERT ◽  
ANDREAS FRITSCHE ◽  
HELMUT ANDERTEN ◽  
KATRIN PEGELOW ◽  
STEFAN PSCHERER ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Insulin Glargine ◽  
Basal Insulin ◽  
Oral Therapy ◽  
Nocturnal Hypoglycemia
Sign in / Sign up

Export Citation Format

Share Document